Did you miss us at AACR Drug Discovery and Development (AACR D3) last week? Download our posters to see the exciting science presented by Morgan Oatley and Keith Maier!
1️⃣🔗https://ow.ly/rbPf50ZstVf
2️⃣🔗https://ow.ly/XiBr50ZstVc
#AACRdrugdev26 #Fiberseq #FFPE #Epigenetics
1️⃣🔗https://ow.ly/rbPf50ZstVf
2️⃣🔗https://ow.ly/XiBr50ZstVc
#AACRdrugdev26 #Fiberseq #FFPE #Epigenetics
July 27, 2026 at 2:05 PM
Did you miss us at AACR Drug Discovery and Development (AACR D3) last week? Download our posters to see the exciting science presented by Morgan Oatley and Keith Maier!
1️⃣🔗https://ow.ly/rbPf50ZstVf
2️⃣🔗https://ow.ly/XiBr50ZstVc
#AACRdrugdev26 #Fiberseq #FFPE #Epigenetics
1️⃣🔗https://ow.ly/rbPf50ZstVf
2️⃣🔗https://ow.ly/XiBr50ZstVc
#AACRdrugdev26 #Fiberseq #FFPE #Epigenetics
David Puleo, Marina Nelen, Chinatsu Sakata, and Ryan Potts discussed "Degraders in the Era of Precision Oncology" in an #AACRdrugdev26 plenary session chaired by Danette Daniels.
@danetteldaniels.bsky.social @pottslab.bsky.social
@danetteldaniels.bsky.social @pottslab.bsky.social
July 24, 2026 at 4:18 PM
David Puleo, Marina Nelen, Chinatsu Sakata, and Ryan Potts discussed "Degraders in the Era of Precision Oncology" in an #AACRdrugdev26 plenary session chaired by Danette Daniels.
@danetteldaniels.bsky.social @pottslab.bsky.social
@danetteldaniels.bsky.social @pottslab.bsky.social
Nobel Laureate and #AACRFellows William G. Kaelin discussed "Genetics as the Rosetta Stone for Cancer Therapeutics" in a keynote lecture at the AACR Conference on Drug Discovery and Development.
#AACRdrugdev26
#AACRdrugdev26
July 24, 2026 at 3:15 PM
Nobel Laureate and #AACRFellows William G. Kaelin discussed "Genetics as the Rosetta Stone for Cancer Therapeutics" in a keynote lecture at the AACR Conference on Drug Discovery and Development.
#AACRdrugdev26
#AACRdrugdev26
Elizabeth Jaffee, Jayesh Desai, Sarah Goldberg, Anthony Joshua, Anirban Maitra, and Puja Sapra discussed "Accelerating Investigator-Initiated Clinical Trials with Team Science" during a special session at #AACRdrugdev26. @anirbanmaitra.bsky.social
July 23, 2026 at 4:35 PM
Elizabeth Jaffee, Jayesh Desai, Sarah Goldberg, Anthony Joshua, Anirban Maitra, and Puja Sapra discussed "Accelerating Investigator-Initiated Clinical Trials with Team Science" during a special session at #AACRdrugdev26. @anirbanmaitra.bsky.social
Elizabeth Jaffee, Jayesh Desai, Sarah Goldberg, Anthony Joshua, Anirban Maitra, and Puja Sapra discussed "Accelerating Investigator-Initiated Clinical Trials with Team Science" during a special session at #AACRdrugdev26. @anirbanmaitra.bsky.social
July 23, 2026 at 4:35 PM
Elizabeth Jaffee, Jayesh Desai, Sarah Goldberg, Anthony Joshua, Anirban Maitra, and Puja Sapra discussed "Accelerating Investigator-Initiated Clinical Trials with Team Science" during a special session at #AACRdrugdev26. @anirbanmaitra.bsky.social
#AACRFellows William Sellers discussed “Therapeutic Resistance as a Path to Combination Therapy” in a keynote lecture during the AACR Conference on Drug Discovery and Development. #AACRdrugdev26
July 23, 2026 at 1:35 PM
#AACRFellows William Sellers discussed “Therapeutic Resistance as a Path to Combination Therapy” in a keynote lecture during the AACR Conference on Drug Discovery and Development. #AACRdrugdev26
AI in Oncology: Facts and Hopes—
Sarah Skerratt, Jorge Reis-Filho, and Benjamin Haibe-Kains addressed this topic in a plenary session at the AACR Conference on Drug Discovery and Development.
#AACRdrugdev26 @bhaibeka.bsky.social
Sarah Skerratt, Jorge Reis-Filho, and Benjamin Haibe-Kains addressed this topic in a plenary session at the AACR Conference on Drug Discovery and Development.
#AACRdrugdev26 @bhaibeka.bsky.social
July 23, 2026 at 1:38 PM
AI in Oncology: Facts and Hopes—
Sarah Skerratt, Jorge Reis-Filho, and Benjamin Haibe-Kains addressed this topic in a plenary session at the AACR Conference on Drug Discovery and Development.
#AACRdrugdev26 @bhaibeka.bsky.social
Sarah Skerratt, Jorge Reis-Filho, and Benjamin Haibe-Kains addressed this topic in a plenary session at the AACR Conference on Drug Discovery and Development.
#AACRdrugdev26 @bhaibeka.bsky.social
Attending #AACRdrugdev26? Join #EpiExpert Morgan Oatley, PhD, at Poster Session B (7/23, 6:15–8:45 p.m.) to explore chromatin profiling insights from FFPE tissues. 🧬 Find her at Poster B012! Download the poster: https://explore.epicypher.com/MO-ffpe-poster-AACRD3-2026
July 23, 2026 at 6:10 PM
Attending #AACRdrugdev26? Join #EpiExpert Morgan Oatley, PhD, at Poster Session B (7/23, 6:15–8:45 p.m.) to explore chromatin profiling insights from FFPE tissues. 🧬 Find her at Poster B012! Download the poster: https://explore.epicypher.com/MO-ffpe-poster-AACRD3-2026
Simultaneous publication with the #AACRDrugDev26 #AACRD3 out now in Clinical Cancer Research
Network Integrated Platform for Clinical Trials Navigation from the New South Wales Early Phase Clinical Trials Alliance aacrjournals.org/clincancerre...
Network Integrated Platform for Clinical Trials Navigation from the New South Wales Early Phase Clinical Trials Alliance aacrjournals.org/clincancerre...
Network Integrated Platform for Clinical Trials Navigation from the New South Wales Early Phase Clinical Trials Alliance
Abstract. Purpose: Access to early-phase clinical trials (EPCTs) is increasingly constrained by delays in genomic testing and lack of coordinated system-level navigation. The New South Wales Early Pha...
aacrjournals.org
July 23, 2026 at 4:01 PM
Simultaneous publication with the #AACRDrugDev26 #AACRD3 out now in Clinical Cancer Research
Network Integrated Platform for Clinical Trials Navigation from the New South Wales Early Phase Clinical Trials Alliance aacrjournals.org/clincancerre...
Network Integrated Platform for Clinical Trials Navigation from the New South Wales Early Phase Clinical Trials Alliance aacrjournals.org/clincancerre...
Poster presenters shared their work with attendees Wednesday evening during the AACR Conference on Drug Discovery and Development. The meeting continues through Friday in Boston. #AACRdrugdev26
July 22, 2026 at 11:58 PM
Poster presenters shared their work with attendees Wednesday evening during the AACR Conference on Drug Discovery and Development. The meeting continues through Friday in Boston. #AACRdrugdev26
Challenges in Drug Discovery: Chemistry—
Kevan Shokat, Kyle Seamon, Nina Ilic-Widlund, and Jonathan Levine discussed this topic in a session at the AACR Conference on Drug Discovery and Development.
#AACRdrugdev26
Kevan Shokat, Kyle Seamon, Nina Ilic-Widlund, and Jonathan Levine discussed this topic in a session at the AACR Conference on Drug Discovery and Development.
#AACRdrugdev26
July 22, 2026 at 10:12 PM
Challenges in Drug Discovery: Chemistry—
Kevan Shokat, Kyle Seamon, Nina Ilic-Widlund, and Jonathan Levine discussed this topic in a session at the AACR Conference on Drug Discovery and Development.
#AACRdrugdev26
Kevan Shokat, Kyle Seamon, Nina Ilic-Widlund, and Jonathan Levine discussed this topic in a session at the AACR Conference on Drug Discovery and Development.
#AACRdrugdev26
EpiCypher's #EpiExpert, Keith Maier, PhD, will be at #AACRdrugdev26 presenting a poster on Fiber-seq's role in genome regulation. Don't miss out!
📍 Poster Session B, July 23rd, 6:15–8:45 p.m. 🧬 Poster B011
Download the poster today:
https://explore.epicypher.com/posters/KM-Fiber-seq-AACRD3-2026
📍 Poster Session B, July 23rd, 6:15–8:45 p.m. 🧬 Poster B011
Download the poster today:
https://explore.epicypher.com/posters/KM-Fiber-seq-AACRD3-2026
July 22, 2026 at 9:10 PM
EpiCypher's #EpiExpert, Keith Maier, PhD, will be at #AACRdrugdev26 presenting a poster on Fiber-seq's role in genome regulation. Don't miss out!
📍 Poster Session B, July 23rd, 6:15–8:45 p.m. 🧬 Poster B011
Download the poster today:
https://explore.epicypher.com/posters/KM-Fiber-seq-AACRD3-2026
📍 Poster Session B, July 23rd, 6:15–8:45 p.m. 🧬 Poster B011
Download the poster today:
https://explore.epicypher.com/posters/KM-Fiber-seq-AACRD3-2026
Marlowe Tessmer, PhD, Executive Editor for Clinical Cancer Research, is attending #AACRdrugdev26 and would love to hear about your research. Connect with her to discuss publishing opportunities in the Journals.
July 22, 2026 at 7:04 PM
Marlowe Tessmer, PhD, Executive Editor for Clinical Cancer Research, is attending #AACRdrugdev26 and would love to hear about your research. Connect with her to discuss publishing opportunities in the Journals.
Challenges in Drug Discovery: Biology—
Paul Workman, Jason M. Sheltzer, Na Zhang, and Eric Spinetti addressed this topic in a session at the AACR Conference on Drug Discovery and Development.
#AACRdrugdev26
Paul Workman, Jason M. Sheltzer, Na Zhang, and Eric Spinetti addressed this topic in a session at the AACR Conference on Drug Discovery and Development.
#AACRdrugdev26
July 22, 2026 at 9:10 PM
Challenges in Drug Discovery: Biology—
Paul Workman, Jason M. Sheltzer, Na Zhang, and Eric Spinetti addressed this topic in a session at the AACR Conference on Drug Discovery and Development.
#AACRdrugdev26
Paul Workman, Jason M. Sheltzer, Na Zhang, and Eric Spinetti addressed this topic in a session at the AACR Conference on Drug Discovery and Development.
#AACRdrugdev26
Read the recently updated Developmental Therapeutics article collection, which highlights the discovery and validation of novel cancer therapeutics, ranging from small molecule inhibitors, degraders, and antibody drug conjugates to immunotherapies. buff.ly/kmTNLnh #AACRdrugdev26
July 22, 2026 at 4:02 PM
Read the recently updated Developmental Therapeutics article collection, which highlights the discovery and validation of novel cancer therapeutics, ranging from small molecule inhibitors, degraders, and antibody drug conjugates to immunotherapies. buff.ly/kmTNLnh #AACRdrugdev26
Read the abstracts from the AACR D3 Conference on Drug Discovery and Development in this supplement to the July 15 issue of Clinical Cancer Research: buff.ly/YofezJA
#AACRdrugdev26
#AACRdrugdev26
July 22, 2026 at 6:03 PM
Read the abstracts from the AACR D3 Conference on Drug Discovery and Development in this supplement to the July 15 issue of Clinical Cancer Research: buff.ly/YofezJA
#AACRdrugdev26
#AACRdrugdev26
Technologies, Biomarkers, and Advanced Diagnostics to Guide Target Discovery and Anticancer Therapies: Maximilian Diehn, Kellie Smith, Issam El Naqa, and Yu Shyr addressed this topic in an #AACRdrugdev26 plenary chaired by Kurt Schalper.
July 22, 2026 at 3:13 PM
Technologies, Biomarkers, and Advanced Diagnostics to Guide Target Discovery and Anticancer Therapies: Maximilian Diehn, Kellie Smith, Issam El Naqa, and Yu Shyr addressed this topic in an #AACRdrugdev26 plenary chaired by Kurt Schalper.
Harmony Turk, PhD, Executive Editor of Cancer Research, is attending #AACRdrugdev26 and would love to hear about your research. Connect with her to discuss publishing opportunities in the Journals.
July 22, 2026 at 3:03 PM
Harmony Turk, PhD, Executive Editor of Cancer Research, is attending #AACRdrugdev26 and would love to hear about your research. Connect with her to discuss publishing opportunities in the Journals.
The first full day of the AACR Conference on Drug Discovery and Development begins soon, featuring special sessions on drugging undruggable targets and challenges in drug discovery.
#AACRdrugdev26
#AACRdrugdev26
July 22, 2026 at 11:32 AM
The first full day of the AACR Conference on Drug Discovery and Development begins soon, featuring special sessions on drugging undruggable targets and challenges in drug discovery.
#AACRdrugdev26
#AACRdrugdev26
Robert Kruger, PhD, Senior Executive Editor for Cancer Discovery, is attending #AACRdrugdev26 and would love to hear about your research. Connect with him to discuss publishing opportunities in the Journals.
July 22, 2026 at 2:01 PM
Robert Kruger, PhD, Senior Executive Editor for Cancer Discovery, is attending #AACRdrugdev26 and would love to hear about your research. Connect with him to discuss publishing opportunities in the Journals.
Andrew Berens hosted a fireside chat with Richard Pazdur—former FDA CDER director and former long-time head of the FDA Oncology Center of Excellence—to kick off day 2 of the AACR Conference on Drug Discovery and Development in Boston.
#AACRdrugdev26
#AACRdrugdev26
July 22, 2026 at 12:15 PM
Andrew Berens hosted a fireside chat with Richard Pazdur—former FDA CDER director and former long-time head of the FDA Oncology Center of Excellence—to kick off day 2 of the AACR Conference on Drug Discovery and Development in Boston.
#AACRdrugdev26
#AACRdrugdev26
Alexis Borisy, Chris Boshoff, and David Schenkein joined in a deeply insightful panel discussion to kick off the AACR Conference on Drug Discovery and Development. #AACRdrugdev26
July 21, 2026 at 11:57 PM
Alexis Borisy, Chris Boshoff, and David Schenkein joined in a deeply insightful panel discussion to kick off the AACR Conference on Drug Discovery and Development. #AACRdrugdev26
AACR President Keith Flaherty, Past Presidents Lillian Siu and Patricia LoRusso, and Board Member Timothy Yap, the cochairs for the AACR Conference on Drug Discovery and Development scientific committee, welcomed attendees to the #AACRdrugdev26 meeting this evening in Boston.
July 21, 2026 at 10:48 PM
AACR President Keith Flaherty, Past Presidents Lillian Siu and Patricia LoRusso, and Board Member Timothy Yap, the cochairs for the AACR Conference on Drug Discovery and Development scientific committee, welcomed attendees to the #AACRdrugdev26 meeting this evening in Boston.
The AACR Conference on Drug Discovery and Development opens today in Boston with keynote lectures by Alexis Borisy, Chris Boshoff, and David Schenkein. #AACRdrugdev26
July 21, 2026 at 7:45 PM
The AACR Conference on Drug Discovery and Development opens today in Boston with keynote lectures by Alexis Borisy, Chris Boshoff, and David Schenkein. #AACRdrugdev26
Read the recently published Molecular Cancer Therapeutics article "Therapeutic targeting of β-catenin in cancer” by Norbert Kraut, who is chairing Educational Session 2 on Case Studies in Drug Discovery and Development at #AACRdrugdev26.
buff.ly/VeA1qDX @norbertkraut.bsky.social #OpenAccess
buff.ly/VeA1qDX @norbertkraut.bsky.social #OpenAccess
July 21, 2026 at 6:30 PM
Read the recently published Molecular Cancer Therapeutics article "Therapeutic targeting of β-catenin in cancer” by Norbert Kraut, who is chairing Educational Session 2 on Case Studies in Drug Discovery and Development at #AACRdrugdev26.
buff.ly/VeA1qDX @norbertkraut.bsky.social #OpenAccess
buff.ly/VeA1qDX @norbertkraut.bsky.social #OpenAccess